GlassScriptPhysician profile
Keith Michael Burger
NPI 1235200510
$4,968.06
in general payments reported to CMS, 2019-2025
20 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,036 · 2022: $829 · 2023: $1,339 · 2024: $1,297 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,103.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,151.46 | 2021-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack, Intracept |
| Janssen Pharmaceuticals, INC | $492.82 | 2023-2024 | Xarelto |
| Abbott Laboratories | $465.00 | 2021-2025 | Proclaim |
| Melinta Therapeutics, LLC | $394.98 | 2023-2025 | Rezzayo, Kimyrsa, Orbactiv |
| Astrazeneca Pharmaceuticals LP | $159.16 | 2021-2024 | Andexxa |
| Depuy Synthes Sales INC. | $154.09 | 2021-2023 | Vivigen Mis Delivery System, Fibergraft Bg Morsels |
| Shionogi INC | $151.82 | 2023-2025 | Fetroja |
| Globus Medical, INC. | $137.44 | 2022-2025 | Cohere, Mars, Coalition Agx |
| La Jolla Pharmaceutical Company | $129.81 | 2023-2025 | Xacduro, Xerava, Zevtera |
| Inspire Medical Systems, INC. | $129.05 | 2023-2025 | Inspire |
| Baxter Healthcare | $119.93 | 2021 | |
| Pfizer INC. | $100.28 | 2023-2025 | |
| Chiesi USA, INC. | $88.70 | 2022 | |
| Gilead Sciences, INC. | $85.60 | 2023-2025 | |
| Si-Bone, INC. | $57.07 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $44.11 | 2023-2024 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.83 | 2023-2024 | Jardiance |
| Cumberland Pharmaceuticals, INC. | $33.33 | 2025 | Caldolor |
| Paratek Pharmaceuticals, INC. | $19.45 | 2025 | Nuzyra |
| Spineology INC. | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.